Ilex Medical Ltd (ILX.TA)
ILA 6040.0
(-4.22%)
ILA 6040.0
(-4.22%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.01 Billion ILS | 13.0% |
| 2022 | 899.18 Million ILS | 2.76% |
| 2021 | 875.06 Million ILS | 12.3% |
| 2020 | 779.24 Million ILS | 33.93% |
| 2019 | 581.85 Million ILS | 9.09% |
| 2018 | 533.37 Million ILS | 9.99% |
| 2017 | 484.91 Million ILS | -0.54% |
| 2016 | 487.55 Million ILS | 1.24% |
| 2015 | 481.6 Million ILS | -4.92% |
| 2014 | 506.54 Million ILS | -5.24% |
| 2013 | 534.54 Million ILS | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 999.48 Million ILS | -1.64% |
| 2024 Q2 | 997.71 Million ILS | -0.18% |
| 2023 Q1 | 901.54 Million ILS | 0.26% |
| 2023 FY | 1.01 Billion ILS | 13.0% |
| 2023 Q3 | 948.6 Million ILS | -1.11% |
| 2023 Q4 | 1.01 Billion ILS | 7.12% |
| 2023 Q2 | 959.29 Million ILS | 6.41% |
| 2022 Q3 | 839.42 Million ILS | 2.77% |
| 2022 Q4 | 899.18 Million ILS | 7.12% |
| 2022 FY | 899.18 Million ILS | 2.76% |
| 2022 Q1 | 907.76 Million ILS | 3.74% |
| 2022 Q2 | 816.82 Million ILS | -10.02% |
| 2021 Q2 | 740.48 Million ILS | -9.97% |
| 2021 Q1 | 822.48 Million ILS | 5.55% |
| 2021 FY | 875.06 Million ILS | 12.3% |
| 2021 Q4 | 875.06 Million ILS | 1.39% |
| 2021 Q3 | 863.03 Million ILS | 16.55% |
| 2020 Q1 | 606.35 Million ILS | 4.21% |
| 2020 FY | 779.24 Million ILS | 33.93% |
| 2020 Q4 | 779.24 Million ILS | 5.07% |
| 2020 Q3 | 741.65 Million ILS | 8.08% |
| 2020 Q2 | 686.21 Million ILS | 13.17% |
| 2019 FY | 581.85 Million ILS | 9.09% |
| 2019 Q4 | 581.85 Million ILS | 3.14% |
| 2019 Q2 | 546.93 Million ILS | -4.88% |
| 2019 Q1 | 574.97 Million ILS | 7.8% |
| 2019 Q3 | 564.14 Million ILS | 3.15% |
| 2018 FY | 533.37 Million ILS | 9.99% |
| 2018 Q1 | 510.21 Million ILS | 5.22% |
| 2018 Q2 | 498.56 Million ILS | -2.28% |
| 2018 Q3 | 495.56 Million ILS | -0.6% |
| 2018 Q4 | 533.37 Million ILS | 7.63% |
| 2017 Q1 | 492.46 Million ILS | 1.01% |
| 2017 Q2 | 495.67 Million ILS | 0.65% |
| 2017 Q3 | 476.96 Million ILS | -3.77% |
| 2017 Q4 | 484.91 Million ILS | 1.67% |
| 2017 FY | 484.91 Million ILS | -0.54% |
| 2016 Q2 | 476.9 Million ILS | -4.72% |
| 2016 Q4 | 487.55 Million ILS | 1.98% |
| 2016 FY | 487.55 Million ILS | 1.24% |
| 2016 Q3 | 478.09 Million ILS | 0.25% |
| 2016 Q1 | 500.53 Million ILS | 3.93% |
| 2015 Q4 | 481.6 Million ILS | -0.04% |
| 2015 Q2 | 494.81 Million ILS | -1.35% |
| 2015 Q1 | 501.6 Million ILS | -0.97% |
| 2015 FY | 481.6 Million ILS | -4.92% |
| 2015 Q3 | 481.77 Million ILS | -2.64% |
| 2014 Q2 | 503.82 Million ILS | -0.31% |
| 2014 Q3 | 482.63 Million ILS | -4.21% |
| 2014 Q4 | 506.54 Million ILS | 4.95% |
| 2014 Q1 | 505.4 Million ILS | -5.45% |
| 2014 FY | 506.54 Million ILS | -5.24% |
| 2013 Q4 | 534.54 Million ILS | -7.04% |
| 2013 FY | 534.54 Million ILS | 0.0% |
| 2013 Q1 | 593.24 Million ILS | 0.0% |
| 2013 Q2 | 584 Million ILS | -1.56% |
| 2013 Q3 | 575 Million ILS | -1.54% |
| Name | Total Assets | Total Assets Difference |
|---|